Biopharmx (BPMX) Releases Earnings Results, Beats Expectations By $0.01 EPS

Biopharmx (NYSEAMERICAN:BPMX) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.01, Fidelity Earnings reports. The firm had revenue of $0.01 million during the quarter.

Shares of BPMX stock opened at $0.10 on Friday. Biopharmx has a 52 week low of $0.05 and a 52 week high of $0.33.

TRADEMARK VIOLATION WARNING: “Biopharmx (BPMX) Releases Earnings Results, Beats Expectations By $0.01 EPS” was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at

Biopharmx Company Profile

BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).

Featured Story: Net Asset Value

Earnings History for Biopharmx (NYSEAMERICAN:BPMX)

Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with's FREE daily email newsletter.